CAS: 155-09-9 - tranylcypromine
Formula:C9H11N
InChI:InChI=1/C9H11N/c10-9-6-8(9)7-4-2-1-3-5-7/h1-5,8-9H,6,10H2/t8-,9+/s2
InChI key:InChIKey=AELCINSCMGFISI-BRJQIKQINA-N
SMILES:NC1CC1C=2C=CC=CC2
- Synonyms:
- (+-)-Trans-2-Phenylcyclopropylamine
- (1R)-2-phenylcyclopropanamine
- (1R,2S)-rel-2-Phenylcyclopropanamine
- (RS)-Tranylcypromine
- (RS)-trans-2-Phenylcyclopropylamine
- 2-Phenylcyclopropanamine
- 2-Phenylcyclopropanamine (Trans)
- Cyclopropanamine, 2-phenyl-, (1R,2S)-rel-
- Cyclopropanamine, 2-phenyl-, trans-(.+-.)-
- Cyclopropylamine, 2-phenyl-, trans-(.+-.)-
- See more synonyms
- Nsc 80664
- Skf 385
- Tranilcipromina
- Transamine
- Tranylcypromin
- dl-Tranylcypromine
- rel-(1R,2S)-2-Phenylcyclopropanamine
- trans-1-Amino-2-phenylcyclopropane
- trans-2-Phenyl-1-cyclopropylamine
- trans-2-Phenylcyclopropan-1-amine
- trans-2-Phenylcyclopropanamine
- trans-Phenylcyclopropylamine
- trans-SKF 385
- trans-dl-2-Phenylcyclopropylamine
Tranylcypromine HCl
Formula:
C9H11N·HCl
Color and Shape:
White To Off-White Solid
Molecular weight:
133.19 36.46
Ref: 4Z-T-671
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire |
Estimated delivery in United States, on Wednesday 8 May 2024
Tranylcypromine
CAS:155-09-9
Tranylcypromine (SKF 385), a potent monoamine oxidase (MAO) inhibitor [1], is used in medicinal applications.
Formula:
C9H11N
Purity:
98%
Molecular weight:
133.19
Ref: TM-T79914
5mg | To inquire | |
50mg | To inquire |
Estimated delivery in United States, on Wednesday 8 May 2024
Ref: 86-MM1687.00
250mg | 290.00 € |
Estimated delivery in United States, on Friday 10 May 2024
trans-(1R,2S)-2-Phenylcyclopropan-1-amine
Controlled ProductCAS:155-09-9
Trans-(1R,2S)-2-phenylcyclopropan-1-amine (TCPA) is a drug that inhibits the enzyme monoamine oxidase. It has been shown …
Formula:
C9H11N
Purity:
Min. 95%
Molecular weight:
133.09 g/mol
Ref: 3D-AAA15509
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Jun 2024